Get the Stockscreener App
93.49
0.07%
-0.07
After Hours:
93.51
0.02
+0.02%
Monster Beverage Corp stock is traded at $93.49, with a volume of 5.80M.
It is down -0.07% in the last 24 hours and down -1.28% over the past month.
Monster Beverage is a leader in the energy drink category within the nonalcoholic ready-to-drink beverage market, generating two-thirds of revenue in the US and Canada. The well-known Monster trademark includes brands such as Monster Energy, Monster Ultra, Java Monster, and Juice Monster. The firm also owns other energy drink brands, such as Reign, NOS, Burn, Bang, and Mother, and brews and distributes beers and flavored malt beverages following the acquisition of a craft brewer in 2022. Monster controls branding and innovation but outsources beverage manufacturing and packaging to co-packers and finished goods distribution to bottlers in the global Coca-Cola system (pursuant to a 20-year agreement inked in 2015). Coke is the largest shareholder of Monster, owning a 20% stake.
See More
Previous Close:
$93.56
Open:
$93.46
24h Volume:
5.80M
Relative Volume:
1.04
Market Cap:
$91.43B
Revenue:
$8.79B
Net Income/Loss:
$2.03B
P/E Ratio:
45.37
EPS:
2.0606
Net Cash Flow:
$2.05B
1W Performance:
-4.11%
1M Performance:
-1.28%
6M Performance:
+14.01%
1Y Performance:
+55.35%
1-Day Range:
$92.95
$93.99
1-Week Range:
$92.95
$97.97
52-Week Range:
$58.09
$100.34
Monster Beverage Corp Stock (MNST) Company Profile
Name
Monster Beverage Corp
Sector
Industry
Phone
909-739-6200
Address
1 MONSTER WAY, CORONA, CA
Compare MNST vs KO, PEP, KOF, COKE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MNST
Monster Beverage Corp
|
93.49 | 91.50B | 8.79B | 2.03B | 2.05B | 2.0606 |
KO
Coca Cola Co
|
82.25 | 349.23B | 49.82B | 13.77B | 12.56B | 3.1761 |
PEP
Pepsico Inc
|
136.64 | 184.19B | 96.91B | 10.52B | 9.28B | 7.6247 |
KOF
Coca Cola Femsa Sab De Cv Adr
|
102.71 | 21.53B | 15.88B | 1.31B | 727.67M | 5.9296 |
COKE
Coca Cola Consolidated Inc
|
184.70 | 11.88B | 7.49B | 578.53M | 665.12M | 6.8502 |
Monster Beverage Corp Stock (MNST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-23-26 | Reiterated | Stifel | Buy |
| Apr-20-26 | Reiterated | TD Cowen | Hold |
| Apr-10-26 | Reiterated | BofA Securities | Buy |
| Apr-08-26 | Reiterated | Wells Fargo | Overweight |
| Apr-07-26 | Reiterated | UBS | Neutral |
| Mar-16-26 | Reiterated | Wells Fargo | Overweight |
| Mar-03-26 | Reiterated | Argus | Buy |
| Feb-27-26 | Reiterated | Citigroup | Buy |
| Feb-27-26 | Reiterated | Deutsche Bank | Buy |
| Feb-27-26 | Reiterated | Evercore ISI | Outperform |
| Feb-27-26 | Reiterated | JP Morgan | Neutral |
| Feb-27-26 | Reiterated | Jefferies | Buy |
| Feb-27-26 | Reiterated | Piper Sandler | Overweight |
| Feb-27-26 | Reiterated | Stifel | Buy |
| Feb-27-26 | Reiterated | TD Cowen | Hold |
| Feb-27-26 | Reiterated | UBS | Neutral |
| Feb-27-26 | Reiterated | Wells Fargo | Overweight |
| Feb-24-26 | Reiterated | RBC Capital Mkts | Outperform |
| Feb-23-26 | Reiterated | Evercore ISI | Outperform |
| Feb-20-26 | Reiterated | Deutsche Bank | Buy |
| Jan-27-26 | Reiterated | Argus | Buy |
| Jan-26-26 | Reiterated | Morgan Stanley | Overweight |
| Jan-16-26 | Upgrade | BNP Paribas Exane | Underperform → Neutral |
| Jan-14-26 | Reiterated | Citigroup | Buy |
| Jan-14-26 | Reiterated | UBS | Neutral |
| Jan-08-26 | Reiterated | TD Cowen | Hold |
| Jan-05-26 | Reiterated | Wells Fargo | Overweight |
| Dec-19-25 | Reiterated | BofA Securities | Buy |
| Dec-03-25 | Reiterated | BMO Capital Markets | Market Perform |
| Dec-03-25 | Reiterated | Goldman | Buy |
| Dec-03-25 | Reiterated | Piper Sandler | Overweight |
| Dec-03-25 | Reiterated | Wells Fargo | Overweight |
| Dec-01-25 | Reiterated | Piper Sandler | Overweight |
| Dec-01-25 | Reiterated | RBC Capital Mkts | Outperform |
| Nov-07-25 | Reiterated | BofA Securities | Buy |
| Nov-07-25 | Reiterated | Deutsche Bank | Buy |
| Nov-07-25 | Reiterated | Evercore ISI | Outperform |
| Nov-07-25 | Reiterated | Goldman | Buy |
| Nov-07-25 | Reiterated | JP Morgan | Neutral |
| Nov-07-25 | Reiterated | Morgan Stanley | Overweight |
| Nov-07-25 | Reiterated | Piper Sandler | Overweight |
| Nov-07-25 | Reiterated | UBS | Neutral |
| Nov-07-25 | Reiterated | Wells Fargo | Overweight |
| Oct-30-25 | Reiterated | Deutsche Bank | Buy |
| Oct-24-25 | Reiterated | JP Morgan | Neutral |
| Oct-24-25 | Reiterated | Stifel | Buy |
| Oct-10-25 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-08-25 | Reiterated | UBS | Neutral |
| Sep-16-25 | Reiterated | Citigroup | Buy |
| Aug-13-25 | Reiterated | Roth Capital | Neutral |
| Aug-08-25 | Reiterated | JP Morgan | Neutral |
| Aug-08-25 | Reiterated | Morgan Stanley | Overweight |
| Aug-08-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-08-25 | Reiterated | RBC Capital Mkts | Outperform |
| Aug-08-25 | Reiterated | UBS | Neutral |
| Aug-08-25 | Reiterated | Wells Fargo | Overweight |
| Jul-17-25 | Reiterated | UBS | Neutral |
| Jul-09-25 | Downgrade | Rothschild & Co Redburn | Buy → Neutral |
| Jun-13-25 | Reiterated | Goldman | Buy |
| Jun-13-25 | Reiterated | Wells Fargo | Overweight |
| Jun-12-25 | Reiterated | Morgan Stanley | Overweight |
| Jun-12-25 | Resumed | Stifel | Buy |
| May-14-25 | Reiterated | Roth Capital | Neutral |
| May-09-25 | Reiterated | JP Morgan | Neutral |
| May-09-25 | Reiterated | Morgan Stanley | Overweight |
| May-09-25 | Reiterated | Piper Sandler | Neutral |
| May-09-25 | Reiterated | TD Cowen | Hold |
| May-09-25 | Reiterated | UBS | Neutral |
| May-05-25 | Reiterated | Wells Fargo | Overweight |
| May-02-25 | Reiterated | JP Morgan | Neutral |
| Apr-25-25 | Reiterated | BofA Securities | Buy |
| Apr-23-25 | Reiterated | Truist | Sell |
| Apr-17-25 | Reiterated | UBS | Neutral |
| Apr-16-25 | Reiterated | Jefferies | Buy |
| Apr-14-25 | Reiterated | Citigroup | Buy |
| Apr-02-25 | Reiterated | Wells Fargo | Overweight |
| Mar-03-25 | Reiterated | UBS | Neutral |
| Feb-28-25 | Reiterated | Citigroup | Buy |
| Feb-28-25 | Reiterated | Deutsche Bank | Buy |
| Feb-28-25 | Reiterated | JP Morgan | Neutral |
| Feb-28-25 | Reiterated | Morgan Stanley | Overweight |
| Dec-19-24 | Reiterated | Exane BNP Paribas | Underperform |
| Dec-06-24 | Initiated | Needham | Hold |
| Nov-12-24 | Reiterated | Argus | Buy |
| Nov-11-24 | Reiterated | TD Cowen | Hold |
| Nov-08-24 | Reiterated | Deutsche Bank | Buy |
| Nov-08-24 | Reiterated | JP Morgan | Neutral |
| Nov-08-24 | Reiterated | Stifel | Buy |
| Nov-08-24 | Reiterated | UBS | Neutral |
| Nov-05-24 | Reiterated | Wells Fargo | Overweight |
| Nov-04-24 | Reiterated | JP Morgan | Neutral |
| Oct-15-24 | Reiterated | BofA Securities | Buy |
| Oct-07-24 | Reiterated | UBS | Neutral |
| Aug-12-24 | Reiterated | ROTH MKM | Neutral |
| Aug-09-24 | Reiterated | Truist | Sell |
| Aug-08-24 | Reiterated | Citigroup | Buy |
| Aug-08-24 | Reiterated | Deutsche Bank | Buy |
| Aug-08-24 | Reiterated | JP Morgan | Neutral |
| Aug-08-24 | Reiterated | Jefferies | Buy |
| Aug-08-24 | Reiterated | Piper Sandler | Neutral |
| Aug-08-24 | Reiterated | RBC Capital Mkts | Outperform |
| Aug-08-24 | Reiterated | UBS | Neutral |
| Aug-08-24 | Reiterated | Wells Fargo | Overweight |
| Jul-23-24 | Reiterated | JP Morgan | Neutral |
| Jul-15-24 | Reiterated | TD Cowen | Hold |
| Jul-10-24 | Reiterated | BofA Securities | Buy |
| Jul-10-24 | Reiterated | Citigroup | Buy |
| Jun-25-24 | Reiterated | Wells Fargo | Overweight |
| Jun-24-24 | Initiated | Exane BNP Paribas | Underperform |
| Jun-17-24 | Reiterated | Stifel | Buy |
| May-03-24 | Reiterated | Morgan Stanley | Overweight |
| May-03-24 | Reiterated | Piper Sandler | Neutral |
| May-03-24 | Reiterated | UBS | Neutral |
| Jan-17-24 | Reiterated | BMO Capital Markets | Market Perform |
| Jan-17-24 | Reiterated | Citigroup | Buy |
| Jan-17-24 | Reiterated | Goldman | Buy |
| Jan-17-24 | Reiterated | JP Morgan | Overweight |
| Nov-20-23 | Reiterated | Piper Sandler | Neutral |
| Nov-20-23 | Reiterated | ROTH MKM | Neutral |
| Nov-13-23 | Initiated | Jefferies | Buy |
| Nov-03-23 | Reiterated | Wells Fargo | Overweight |
| Oct-31-23 | Reiterated | JP Morgan | Overweight |
| Oct-24-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Oct-23-23 | Reiterated | Deutsche Bank | Buy |
| Oct-05-23 | Upgrade | CFRA | Hold → Buy |
| Aug-14-23 | Initiated | HSBC Securities | Buy |
| Aug-10-23 | Reiterated | ROTH MKM | Neutral |
| Aug-07-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-04-23 | Reiterated | UBS | Neutral |
| Jul-31-23 | Reiterated | Stifel | Buy |
| Jul-25-23 | Reiterated | Evercore ISI | Outperform |
| Jun-08-23 | Initiated | Piper Sandler | Neutral |
| May-08-23 | Reiterated | BMO Capital Markets | Market Perform |
| May-08-23 | Reiterated | ROTH MKM | Neutral |
| May-05-23 | Reiterated | BofA Securities | Buy |
| May-05-23 | Reiterated | Citigroup | Buy |
| May-05-23 | Reiterated | Deutsche Bank | Buy |
| May-05-23 | Reiterated | Goldman | Buy |
| May-05-23 | Reiterated | JP Morgan | Overweight |
| May-05-23 | Reiterated | Morgan Stanley | Overweight |
| May-05-23 | Reiterated | RBC Capital Mkts | Outperform |
| May-05-23 | Reiterated | Truist | Buy |
| May-05-23 | Reiterated | UBS | Neutral |
| May-05-23 | Reiterated | Wells Fargo | Overweight |
| Apr-06-23 | Reiterated | UBS | Neutral |
| Apr-06-23 | Reiterated | Wedbush | Neutral |
| Mar-06-23 | Upgrade | Redburn | Neutral → Buy |
| Mar-01-23 | Reiterated | BMO Capital Markets | Market Perform |
| Mar-01-23 | Downgrade | CFRA | Buy → Hold |
| Mar-01-23 | Reiterated | Citigroup | Buy |
| Mar-01-23 | Reiterated | JP Morgan | Overweight |
| Mar-01-23 | Reiterated | Morgan Stanley | Overweight |
| Mar-01-23 | Reiterated | Truist | Buy |
| Mar-01-23 | Reiterated | Wells Fargo | Overweight |
| Feb-17-23 | Initiated | Citigroup | Buy |
| Jan-18-23 | Reiterated | BMO Capital Markets | Market Perform |
| Jan-18-23 | Reiterated | Evercore ISI | Outperform |
| Nov-04-22 | Reiterated | BofA Securities | Buy |
| Nov-04-22 | Reiterated | Morgan Stanley | Overweight |
| Nov-04-22 | Reiterated | RBC Capital Mkts | Outperform |
| Nov-04-22 | Reiterated | UBS | Neutral |
| Nov-04-22 | Reiterated | Wells Fargo | Overweight |
| Nov-01-22 | Upgrade | JP Morgan | Neutral → Overweight |
| Oct-11-22 | Initiated | Wedbush | Neutral |
| Aug-05-22 | Reiterated | RBC Capital Mkts | Outperform |
| Jul-05-22 | Initiated | ROTH Capital | Neutral |
| Jun-06-22 | Reiterated | Morgan Stanley | Overweight |
| May-18-22 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Feb-25-22 | Reiterated | Citigroup | Buy |
| Feb-25-22 | Reiterated | Cowen | Market Perform |
| Feb-25-22 | Reiterated | Deutsche Bank | Buy |
| Feb-25-22 | Reiterated | Guggenheim | Buy |
| Feb-25-22 | Reiterated | JP Morgan | Neutral |
| Feb-17-22 | Initiated | BMO Capital Markets | Market Perform |
| Nov-01-21 | Initiated | Redburn | Neutral |
| Oct-13-21 | Downgrade | Jefferies | Buy → Hold |
| Jul-23-21 | Upgrade | Citigroup | Neutral → Buy |
| May-07-21 | Reiterated | Truist | Buy |
| Feb-26-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Jan-20-21 | Initiated | Bernstein | Mkt Perform |
| Jan-15-21 | Reiterated | Citigroup | Neutral |
| Jan-15-21 | Reiterated | Deutsche Bank | Buy |
| Jan-15-21 | Reiterated | Truist | Buy |
| Dec-10-20 | Reiterated | Morgan Stanley | Overweight |
| Dec-08-20 | Initiated | Wells Fargo | Overweight |
| Nov-17-20 | Upgrade | UBS | Sell → Neutral |
| Nov-03-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-20-20 | Reiterated | Guggenheim | Buy |
| May-28-20 | Reiterated | Stifel | Buy |
| May-11-20 | Downgrade | Citigroup | Buy → Neutral |
| May-05-20 | Reiterated | Guggenheim | Buy |
| Apr-16-20 | Resumed | BofA/Merrill | Buy |
| Apr-01-20 | Resumed | Goldman | Buy |
| Mar-20-20 | Upgrade | Guggenheim | Neutral → Buy |
| Mar-18-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Feb-03-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-17-19 | Downgrade | Cowen | Outperform → Market Perform |
| Oct-02-19 | Downgrade | Guggenheim | Buy → Neutral |
| Aug-08-19 | Reiterated | BMO Capital Markets | Market Perform |
| Aug-08-19 | Reiterated | Morgan Stanley | Equal-Weight |
| Aug-08-19 | Reiterated | UBS | Sell |
| Apr-01-19 | Downgrade | Macquarie | Outperform → Neutral |
| Mar-28-19 | Reiterated | Morgan Stanley | Equal-Weight |
View All
Monster Beverage Corp Stock (MNST) Latest News
5 Beverage Stocks Primed for Q2 Earnings Beat in the Coming Weeks - TradingView
Monster Energy Pipeline Punch by Monster Beveragetropical blend boosts lineup - AD HOC NEWS
Monster Beverage (NASDAQ:MNST) Stock Passes Above 200-Day Moving AverageHere's Why - MarketBeat
Monster Beverage Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Monster Beverage (MNST) Stock Forum and Discussion - Moomoo
Monster Energy Pipeline Punch by Monster Beverage Corp.tropical variant supports core lineup - AD HOC NEWS
Monster Beverage Corp. stock outperforms competitors on strong trading day - MarketWatch
The Bull Case For Monster Beverage (MNST) Could Change Following Deutsche Bank’s Valuation-Driven Downgrade - simplywall.st
Monster Beverage up 23% YTD on Strong Sales, Institutional Support - Yahoo Finance
Pipeline Punch by Monster Energyfruit-heavy blend for accessory cans - Ad-hoc-news.de
Monster Beverage Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Monster Beverage earnings preview: What to expect - MSN
Is MNST Overvalued? DCF Says Worth $44 - GuruFocus
Monster Beverage Earnings Preview: What to Expect - Yahoo Finance
Monster Beverage (MNST) Downgraded by Deutsche Bank, Shares Dip - GuruFocus
Monster Continues to Leverage Its Brand With Zero Sugar Innovations and New Markets - Morningstar
Monster Beverage Corp. stock underperforms Monday when compared to competitors - MarketWatch
BMO raises Monster Beverage stock price target to $95 on growth - Investing.com Nigeria
Monster Beverage stock downgraded by Deutsche Bank as valuation limits upside - Yahoo Finance
Monster Beverage downgraded to Hold as valuation seen limiting further upside - Yahoo Finance
This Charles Schwab Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday - Benzinga
MNST Downgraded by Deutsche Bank -- Price Target Raised to $98.0 - GuruFocus
Deutsche Bank downgrades Monster Beverage stock rating on valuation concerns - Investing.com Nigeria
MONSTER BEVERAGE CORP : BMO RAISES TARGET PRICE TO $95 FROM $73 - Bitget
Monster Beverage stock steadies as energy drink demand supports earnings outlook - AD HOC NEWS
Monster Beverage (MNST) Announces A 2 For 1 Stock Split, Is It Fully Priced? - simplywall.st
Monster Beverage Corp. stock outperforms competitors despite losses on the day - MarketWatch
Support test in focus. Can MNST avoid deeper losses? - Traders Union
Why is Monster Beverage stock sliding today? - Investing.com
MNST Stock Update: Midday Trading Shows Slight Increase - GuruFocus
Monster Beverage (MNST) Stock Looks Above Fair Value After Split News - simplywall.st
Monster Beverage stock holds near record territory as energy drink demand fuels double digit growth - ad-hoc-news.de
Is Monster Beverage (MNST) Fully Priced After Its Stock Split? - Yahoo Finance
Monster Beverage Corp. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
UK to Ban High-Caffeine Energy Drinks for Kids, Impacting Major Brands - GuruFocus
MNST Maintained by Stifel -- Price Target Raised to $105 - GuruFocus
UK finalizes plan to ban high-caffeine energy drink sales to children (PEP:NASDAQ) - Seeking Alpha
Weak Investor Sentiment Overshadows Energy Drink Maker's Strong Growth - Benzinga
Monster Beverage (NASDAQ:MNST) Sets New 12-Month High Following Analyst Upgrade - MarketBeat
Monster Beverage (NASDAQ:MNST) Stock Price Expected to Rise, UBS Group Analyst Says - MarketBeat
Monster Beverage stock hits 52-week high at 99.16 USD By Investing.com - Investing.com Australia
Monster Beverage stock hits 52-week high at 99.16 USD - Investing.com
Stifel raises Monster Beverage stock price target on innovation - Investing.com
Stifel raises Monster Beverage stock price target on innovation By Investing.com - Investing.com UK
Monster Energy Pipeline PunchMonster Beverage bets on fruit-heavy cans - ad-hoc-news.de
Monster Beverage (MNST) Could Be 9% Overvalued Following Its Latest Share Price Run - Yahoo Finance
Will Monster Beverage (MNST) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Monster Beverage stock reflects steady growth as energy drinks remain in demand - ad-hoc-news.de
Monster Beverage approves 2-for-1 stock split By Investing.com - Investing.com Nigeria
Citigroup Adjusts Price Target on Monster Beverage to $113 From $100, Maintains Buy Rating - Moomoo
MNST Maintained by Citigroup -- Price Target Raised to $113 - GuruFocus
Monster Beverage Corp Stock (MNST) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.22%
0.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):